000			02171 a2200649 4500
005			20250515074250.0
264		0	_c20071015
008			200710s 0 0 eng d
022			_a1476-4598
024	7		_a10.1186/1476-4598-6-48 _2doi
040			_aNLM _beng _cNLM
100	1		_aKashiwagi, Hiroyuki
245	0	0	_aSelective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy. _h[electronic resource]
260			_bMolecular cancer _cJul 2007
300			_a48 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xmetabolism
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aAzabicyclo Compounds _xmetabolism
650	0	4	_aBinding, Competitive
650	0	4	_aBrain _xcytology
650	0	4	_aCarbamates _xmetabolism
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKidney _xcytology
650	0	4	_aLigands
650	0	4	_aLung _xcytology
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aNeoplasms, Experimental _xdrug therapy
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aPositron-Emission Tomography
650	0	4	_aRadioligand Assay
650	0	4	_aReceptors, sigma _xagonists
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSurvival Analysis
650	0	4	_aTritium
700	1		_aMcDunn, Jonathan E
700	1		_aSimon, Peter O
700	1		_aGoedegebuure, Peter S
700	1		_aXu, Jinbin
700	1		_aJones, Lynne
700	1		_aChang, Katherine
700	1		_aJohnston, Fabian
700	1		_aTrinkaus, Kathryn
700	1		_aHotchkiss, Richard S
700	1		_aMach, Robert H
700	1		_aHawkins, William G
773	0		_tMolecular cancer _gvol. 6 _gp. 48
856	4	0	_uhttps://doi.org/10.1186/1476-4598-6-48 _zAvailable from publisher's website
999			_c17166490 _d17166490